Renal hemodynamic effects of lovastatin in a renal ablation model.

@article{Hafez1996RenalHE,
  title={Renal hemodynamic effects of lovastatin in a renal ablation model.},
  author={Khaled S. Hafez and Sharon R. Inman and Nicholas T. Stowe and Andrew C. Novick},
  journal={Urology},
  year={1996},
  volume={48 6},
  pages={
          862-7
        }
}
OBJECTIVES Patients with renal mass reduction of more than 50% are at increased risk for progressive renal failure. Lipid-lowering agents have been shown to preserve renal function in various models of chronic renal failure. This study was performed to evaluate the hemodynamic effects of lovastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in the remnant kidney model. METHODS Two groups of animals were studied. Group 1 (n = 9) served as controls and group 2 (n = 14… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2016

Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease.

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2001